Krebs Biochemicals Announces 34th AGM on Sep 29, 2026
Krebs Biochemicals & Industries Limited will hold its 34th AGM on September 29, 2026, at 11:30 AM IST via VC/OAVM. The annual report and financial statements for FY2025-26 will be emailed to shareholders and available online. E-voting facilities will be provided.
This is a standard procedural announcement for an AGM, which is a regular corporate event and typically has a low immediate impact on the stock price.
The announcement is a routine corporate communication regarding the Annual General Meeting and does not contain any significant financial or operational updates that would impact the sentiment.
Krebs Biochemicals & Industries Limited has issued a notice regarding its 34th Annual General Meeting (AGM). The AGM is scheduled to be held on Tuesday, September 29, 2026, at 11:30 AM IST. In compliance with current regulations, the meeting will be conducted through Video Conferencing/Other Audio Visual Means (VC/OAVM).
The company will send the Notice of AGM, Financial Statements for the fiscal year 2025-26, Board of Directors' Reports, Auditors' Reports, and other necessary documents via email to all registered shareholders. These documents will also be available on the company's website (www.krebsbiochem.com), the BSE (www.bseindia.com), and the NSE (www.nse-india.com) websites, as well as on the KFin Technologies Limited website (https://evoting.kfintech.com).
Members will have the facility to exercise their voting rights on the agenda items through electronic means, utilizing the e-voting services provided by KFin Technologies Ltd. Detailed procedures for remote e-voting and e-voting during the AGM are provided in the AGM notice, which will be sent shortly. Shareholders holding shares in physical mode are requested to update their email addresses and bank details by emailing com_sec@krebsbiochem.com or RTA at einward.ris@kfintech.com, providing necessary documentation. For shares held in demat mode, members should contact their Depository Participant (DP) to update their details. The company also stated that members can write to them for any assistance regarding this matter.
A plain-language summary of a public exchange filing by Krebs Biochemicals and Industries Limited. Read the original for the full detail.